Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT01295307 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT01295307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01295307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Lead sponsor
Technische Universität Dresden
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2011
Completion date
December 31, 2013
Enrollment
86 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia